Vanguard Personalized Indexing Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.7M | Buy |
10,853
+792
| +8% | +$416K | 0.06% | 261 |
|
|
2025
Q1 | $6.38M | Sell |
10,061
-130
| -1% | -$82.4K | 0.09% | 185 |
|
|
2024
Q4 | $7.26M | Sell |
10,191
-414
| -4% | -$295K | 0.11% | 154 |
|
|
2024
Q3 | $11.1M | Buy |
10,605
+1,046
| +11% | +$1.1M | 0.18% | 95 |
|
|
2024
Q2 | $10M | Buy |
9,559
+1,129
| +13% | +$1.19M | 0.19% | 87 |
|
|
2024
Q1 | $8.11M | Buy |
8,430
+386
| +5% | +$372K | 0.17% | 95 |
|
|
2023
Q4 | $7.06M | Buy |
8,044
+75
| +0.9% | +$65.9K | 0.18% | 96 |
|
|
2023
Q3 | $6.56M | Buy |
7,969
+810
| +11% | +$667K | 0.2% | 82 |
|
|
2023
Q2 | $5.14M | Buy |
7,159
+253
| +4% | +$182K | 0.16% | 104 |
|
|
2023
Q1 | $5.67M | Buy |
6,906
+560
| +9% | +$460K | 0.2% | 92 |
|
|
2022
Q4 | $4.58M | Buy |
6,346
+152
| +2% | +$110K | 0.19% | 100 |
|
|
2022
Q3 | $4.27M | Buy |
6,194
+966
| +18% | +$665K | 0.19% | 88 |
|
|
2022
Q2 | $3.09M | Buy |
5,228
+1,281
| +32% | +$757K | 0.14% | 126 |
|
|
2022
Q1 | $2.76M | Buy |
3,947
+1,166
| +42% | +$814K | 0.13% | 134 |
|
|
2021
Q4 | $1.76M | Buy |
2,781
+441
| +19% | +$278K | 0.1% | 196 |
|
|
2021
Q3 | $1.42M | Buy |
2,340
+461
| +25% | +$279K | 0.13% | 157 |
|
|
2021
Q2 | $1.05M | Buy |
1,879
+667
| +55% | +$372K | 0.11% | 187 |
|
|
2021
Q1 | $573K | Buy |
1,212
+16
| +1% | +$7.56K | 0.09% | 281 |
|
|
2020
Q4 | $578K | Sell |
1,196
-48
| -4% | -$23.2K | 0.13% | 189 |
|
|
2020
Q3 | $696K | Buy |
1,244
+144
| +13% | +$80.6K | 0.2% | 125 |
|
|
2020
Q2 | $686K | Buy |
1,100
+59
| +6% | +$36.8K | 0.31% | 74 |
|
|
2020
Q1 | $508K | Buy |
+1,041
| New | +$508K | 0.3% | 93 |
|